Gil Herling works as an Investor at Medison. The firm's known portfolio counts 1 company.
Is Gil Herling a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
- Focus
- BiotechClinical-stageDrug Discovery
Contacts
Affiliated funds' portfolios
Investor at Medison, whose known portfolio counts 1 company
- Keros Therapeutics
Investor Profile
Gil Herling is listed against sector Healthcare, and focus areas Biotech, Clinical-stage and Drug Discovery in the database.
The stage tags on this profile are Growth and Series B.
What the affiliated firm has backed is the closest available signal on whether Gil Herling is worth approaching.
Colleagues at Medison
Frequently asked questions
Who is Gil Herling?
Gil Herling is a corporate venture investor based in Netanya, Israel, listed as Investor at Medison. The known portfolio of that firm is one company. That portfolio belongs to the firm, not to Gil Herling personally.
What does Gil Herling invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Clinical-stage and Drug Discovery. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Gil Herling invest at?
Medison is listed for Growth and Series B rounds in the database, and Gil Herling is listed there as Investor. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Gil Herling listed at?
Gil Herling is listed as Investor at Medison. 3 other people in the database share a firm with Gil Herling.
How do I contact Gil Herling?
A LinkedIn page is on file for Gil Herling. It is readable inside RaiseHunt after you create an account. The database holds no email address and no phone number for this profile.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal